Meyka Pro banner
Carbon Revolution Public Limited Ordinary Shares

Stay Updated with the Latest Carbon Revolution Public Limited Ordinary Shares CREV News in Real Time

Find CREV news now at Meyka AI. Stay informed with the latest Carbon Revolution Public Limited Ordinary Shares stocks updates, including price news, market analysis, and expert insights.

CREVNASDAQ
Consumer CyclicalAuto - Parts
$0.40
$0.40(402000.01%)
U.S. Market is Open · 15:50
Formula 1 Returns to Malaysia: Sepang to Host Bahrain Grand Prix Oct 2-4, 2026
📅 in about 4 hours

Formula 1 Returns to Malaysia: Sepang to Host Bahrain Grand Prix Oct 2-4, 2026

Formula 1 returns to Malaysia after 9 years. Sepang will host the 2026 Bahrain Grand Prix Oct 2-4. Bahrain covers USD 70-80M hosting fee; Malaysia spends RM40M on upgrades. Hotels and tourism expected to benefit.

Read more 12
SSI Recipients Get August Payment Early on July 31 as Calendar Shifts Benefits
📅 in about 4 hours

SSI Recipients Get August Payment Early on July 31 as Calendar Shifts Benefits

SSI recipients will get their August 2026 payment on Friday, July 31, not August 1. The shift happens because August 1 is a Saturday. No benefits are lost; the total for 2026 remains unchanged.

Read more 12
Harvey Norman Copped $35M Fine Over Misleading Ads on July 29
📅 in about 2 hours

Harvey Norman Copped $35M Fine Over Misleading Ads on July 29

Harvey Norman ordered to pay $35 million penalty after Federal Court found its 60-month interest-free ads masked mandatory credit card fees. Latitude Financial pays $20 million. Combined $55 million is ASIC’s record for misleading financial product marketing.

Read more 12
RBA’s Bullock Signals Fourth Rate Hike as Housing Market Softens on July 29
📅 in about 1 hour

RBA’s Bullock Signals Fourth Rate Hike as Housing Market Softens on July 29

RBA Governor Michele Bullock signals potential fourth rate hike in August while acknowledging housing weakness. Underlying inflation sits at 3.6%, above the RBA’s 2-3% target. Markets now price August hike at just 21% probability.

Read more 12
Qantas Launches Massive Sale: 400,000 Fares From $359 on July 28
📅 1 hour ago

Qantas Launches Massive Sale: 400,000 Fares From $359 on July 28

Qantas launches major international sale with 400,000 fares starting at $359 one-way to Auckland. Economy return fares to Las Vegas start at $1,199 on the new non-stop route launching December 29, 2026.

Read more 12
US Walks Out on France at UN Security Council Over Human Rights Vote July 28
📅 1 hour ago

US Walks Out on France at UN Security Council Over Human Rights Vote July 28

US diplomats walked out of a UN Security Council meeting on Monday after France compared America’s human rights voting record to North Korea and Russia. The row stems from US opposition to extending UN rights chief Volker Turk’s term.

Read more 12
FTSE 100 Rises 0.22% as Markets Recover From Chip Sell-Off, Middle East Risks Persist
📅 2 hours ago

FTSE 100 Rises 0.22% as Markets Recover From Chip Sell-Off, Middle East Risks Persist

On July 28, 2026, the FTSE 100 advanced 0.22%, bouncing back after a sharp global sell-off in semiconductor stocks unsettled investors earlier in the week. Strong corporate earnings and bargain buying helped support the UK’s benchmark index, while tensions in the Middle East continued to keep traders cautious. Investors are weighing encouraging company results against…

Read more 12
10Y Treasury ~4.62% as Oil Slides; Yield Curve Holds Positive Slope (30Y ~5.11%)
📅 3 hours ago

10Y Treasury ~4.62% as Oil Slides; Yield Curve Holds Positive Slope (30Y ~5.11%)

The 10-year Treasury yield eased to roughly 4.62% on July 28, 2026, pulling back from last week’s highs. Brent crude fell to $86.58 a barrel, down 1.54% on the day, as hopes grew for renewed US-Iran talks. The 30-year Treasury yield slipped to 5.111%, while the 2-year fell to 4.301%. Despite the pullback, the Treasury…

Read more 12
FDA Issues Class II Recall for Subpotent Levothyroxine Tablets on July 28
📅 3 hours ago

FDA Issues Class II Recall for Subpotent Levothyroxine Tablets on July 28

Major Pharmaceuticals recalls levothyroxine sodium tablets nationwide due to subpotency. The FDA classified it as a Class II recall on July 17. Affected patients should consult their doctor and return medication to the pharmacy.

Read more 12

CREV News FAQ